USFDA issues Form-483 with two observations for Lupin’s Nagpur plant
The US Food and Drug Administration (USFDA) has issued Form-483 with two observations for Lupin's Nagpur oral solid dosage facility.According to USFDA, the Form 483 is issued to a ...
